Hassan, S. S., Mukhtar, E. J. H. A., & Madlum, K. N. (2022). Metabolic pathways inhibitors can affect the therapeutic efficiency of doxorubicin. International Journal of Health Sciences, 6(S2), 9099–9108. https://doi.org/10.53730/ijhs.v6nS2.7375